according to calculations by the ministry of health patient copayment levels calculated for reimbursable drugs only could be reduced from at present to if patients were always dispensed the cheapest generic dmg with the act on reimbursement of drugs pharmacists no longer have any financial incentives to dispense the more expensive drugs as the markups are equal within the same substance group figure shows how heterogeneous the size of phi markets is across countries